Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Lexicon Pharmaceuticals Inc. (LXRX)

   0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the treatment of type 1 and is in Phase III clinical trials for the treatment of type 2 diabetes; LX9211, which is in Phase I clinical development for the treatment of neuropathic pain; and LX2761 that is in Phase I clinical development for the treatment of diabetes. The company has strategic collaboration and license agreements with Ipsen Pharma SAS; Bristol-Myers Squibb Company; and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.043 - 2.05 2.05 - 2.056
Low: 1.93 - 1.939 1.939 - 1.947
Close: 2.016 - 2.03 2.03 - 2.042

Technical analysis

as of: 2020-07-01 4:34:48 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 2.45     One year: 2.66
Support: Support1: 1.81    Support2: 1.51
Resistance: Resistance1: 2.10    Resistance2: 2.28
Pivot: 1.96
Moving Average: MA(5): 2.01     MA(20): 1.95
MA(100): 2.18     MA(250): 2.97
MACD: MACD(12,26): 0.01     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 41.13     %D(3): 42.55
RSI: RSI(14): 54.52
52-week: High: 6.65  Low: 1.13  Change(%): -69.5
Average Vol(K): 3-Month: 93895  10-Days: 92432

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
LXRX has closed below upper band by 32.4%. Bollinger Bands are 34.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 30 Jun 2020
Lexicon Pharmaceuticals, Inc. (LXRX) Stock: Buy, Hold, or Sell? - InvestorsObserver

Mon, 29 Jun 2020
Lexicon Pharmaceuticals Inc. (LXRX) Open at price of $2.01: A Brand-New Opportunity for Investors - News Daemon

Mon, 29 Jun 2020
Analyzing Future Direction of Lexicon Pharmaceuticals, Inc. (LXRX): Next Earning Report on 07/29/2020 - The News Heater

Tue, 23 Jun 2020
Growth Curve Analysis: Lexicon Pharmaceuticals, Inc. (LXRX) grow 2.03% in last 30 days - The News Heater

Fri, 19 Jun 2020
Top Moving Stock Now – Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Stocks Register

Mon, 15 Jun 2020
Lexicon Pharmaceuticals Inc. (LXRX) distance from 200-day Simple Moving Average is $2.9326: Right on the Precipice - News Daemon

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 107
Shares Float (M) 44
% Held by Insiders 5.23
% Held by Institutions 101.48
Shares Short (K) 10,920
Shares Short P. Month (K) 10,420

Stock Financials

EPS 0.773
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.510
Profit Margin 26.59
Operating Margin 38.99
Return on Assets (ttm) 24.9
Return on Equity (ttm) 1877.2
Qtrly Rev. Growth -13.2
Gross Profit (p.s.) 2.121
Sales Per Share 3.000
EBITDA (p.s.) 1.187
Qtrly Earnings Growth
Operating Cash Flow (M) 117
Levered Free Cash Flow (M) 100

Stock Valuations

PE Ratio 2.63
PEG Ratio
Price to Book value 3.98
Price to Sales 0.68
Price to Cash Flow 1.85

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.